Does Low-Dose Naltrexone help with fatigue after COVID?
Low-Dose Naltrexone did not reduce fatigue more than a dummy pill over four months in a Canadian study of 160 adults.
The Sick Times reported these early findings before formal review by other experts. The study tested Low-Dose Naltrexone, a medicine given in small daily amounts. People in the study had developed myalgic encephalomyelitis after COVID. This is a long-term illness that can cause severe fatigue. That makes the findings relevant to our Chronic Fatigue community, though they do not cover every cause of tiredness.
People took the medicine or a placebo, a pill without active medicine. The medicine dose started at 1 milligram per day. It rose to as much as 4.5 milligrams, depending on tolerance. Researchers measured fatigue using a questionnaire called the Fatigue Severity Scale. Fatigue improved at a similar rate in both groups. The report did not give the exact changes in scores.
The authors noted that this differed from earlier studies without a comparison group. It also contrasted with broad support for the medicine among patients and clinicians. The key distinction is not whether people felt better while taking it. It is whether they improved more than people taking the dummy pill.
For members tracking fatigue, that distinction can help frame community conversations. A record of symptom scores, dates, and daily function offers useful context. Notes about dose changes and other routine changes can add detail. Comparing those records may reveal shared patterns without proving what caused an improvement. This result leaves room for individual experiences, but does not show an added fatigue benefit in this group.
What have your own fatigue scores or daily-life notes shown over time?


Comments
No comments yet.